Table 3 Cardiovascular mortality in patients with and without DM in different patients subgroups
From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
Factor present | ||||||
|---|---|---|---|---|---|---|
Yes | No | |||||
DM | Non-DM | P value | DM | Non-DM | P value | |
Age > 80 (%) | 4.6 | 1.9 | 0.093 | 1.0 | 0.0 | 0.003 |
Female gender (%) | 4.1 | 0.5 | 0.001 | 0.7 | 0.3 | 0.409 |
Hypertension (%) | 2.3 | 0.5 | 0.002 | 0.0 | 0.2 | 1.000 |
Hypercholesterolemia (%) | 2.0 | 0.6 | 0.023 | 1.5 | 0.1 | 0.032 |
Smoking (%) | 0.5 | 0.0 | 0.335 | 2.3 | 0.5 | 0.002 |
Chronic renal failure (%) | 7.7 | 1.9 | 0.083 | 1.0 | 0.3 | 0.079 |
Peripheral artery disease (%) | 0.0 | 0.0 | 1.000 | 2.2 | 0.5 | < 0.001 |
Previous CAD (%) | 1.4 | 0.5 | 0.244 | 2.3 | 0.4 | 0.002 |
Previous infarction (%) | 0.8 | 0.6 | 1.000 | 2.1 | 0.4 | < 0.001 |
Previous PCI (%) | 1.8 | 0.4 | 0.312 | 1.9 | 0.4 | 0.004 |
Previous CABG (%) | 0.0 | 2.1 | 1.000 | 2.0 | 0.4 | < 0.001 |
Previous valve replacement (%) | 4.3 | 0.0 | 0.253 | 1.7 | 0.4 | 0.002 |
Left ventricular dysfunction (%) | 1.1 | 0.7 | 0.635 | 2.2 | 0.4 | 0.001 |
NYHA > 2 (%) | 5.1 | 1.2 | 0.049 | 1.6 | 0.2 | 0.004 |
CCS > 2 (%) | 3.2 | 2.9 | 1.000 | 1.8 | 0.2 | < 0.001 |